Elizabeth Barrett

CEO

Board Member

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

Affiliation history

Recorded current and former roles; source labels appear when available.

Recorded roles and earnings-call appearances connecting this person to public companies.

URGN

Current role

CEO, Board Member

6 calls Latest call 2025-11-06

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year	Company	Role	Salary	Bonus	Stock awards	Option awards	Incentive	Other	Total
2025	UroGen Pharma Ltd. (URGN)	Chief Executive Officer	$855,590	$774,066	$2,122,211	—	$516,263	$42,494	$4,310,624
2024	UroGen Pharma Ltd. (URGN)	Chief Executive Officer	$826,013	—	$2,751,111	—	$529,981	$42,753	$4,149,858
2023	UroGen Pharma Ltd. (URGN)	Chief Executive Officer	$794,243	$19,984	$2,464,250	$836,533	$479,620	$44,959	$4,639,589
2022	UroGen Pharma Ltd. (URGN)	Chief Executive Officer	$764,290	—	—	$753,195	$307,449	$45,626	$1,870,560
2021	UroGen Pharma Ltd. (URGN)	Chief Executive Officer	$739,025	—	$882,800	$2,230,095	$315,618	$45,128	$4,212,666
2020	UroGen Pharma Ltd. (URGN)	Chief Executive Officer	$636,987	—	$441,150	$876,164	$468,650	$43,716	$2,466,667
2019	UroGen Pharma Ltd. (URGN)	Chief Executive Officer	$694,697	$300,000	$15,082,782	$8,979,216	$840,000	$4,128	$25,900,823

Earnings-call appearances and filed executive appointments or departures, newest first.